PharmExtracta SpA

PharmExtracta SpA is an Italian pharmaceutical and nutraceutical company headquartered in Pontenure, Italy. It was formed through the merger of Omeopiacenza s.r.l. and PharmExtracta s.r.l., and has operated in the pharmaceutical and nutraceutical sector for more than 30 years. The company describes itself as a "biofarmaceutica vegetale per la salute" (plant-based biopharmaceutical for health), emphasizing research and development in phytotherapy, probiotics, and nutraceuticals. PharmExtracta's R&D department combines unique knowledge in herbal, probiotic, and nutraceutical fields with ongoing communication with physicians to create formulations that the company positions as among the most innovative on the market. The company states that its products are supported by 40 patents and more than 200 scientific publications in leading journals of the sector. PharmExtracta's product portfolio is organized into three lines: Biofarmaceutica, which aims to optimize the pharmacological and clinical yield of nutraceutical substances and herbal derivatives; Metabolic Care, consisting of innovative formulations studied for metabolic aspects; and Bacterial Care, which includes a line of typed and safe probiotics and bioproducts. The company operates primarily in the Italian market and maintains a direct relationship with healthcare professionals. As of available evidence, PharmExtracta SpA is an active company. Its headquarters are in Pontenure, Italy, and its official website is pharmextracta.com. The company's legal form is a Società per Azioni (SpA), indicating a joint-stock company under Italian law.

PharmExtracta SpA was established through the merger of Omeopiacenza s.r.l. and PharmExtracta s.r.l. The combined entity has operated in the pharmaceutical and nutraceutical sector for more than 30 years, according to the company's official website. The company is headquartered in Pontenure, Italy, as indicated by Wikidata. The company's history is rooted in the integration of homeopathic and plant-based pharmaceutical expertise (Omeopiacenza) with nutraceutical and phytotherapeutic research (PharmExtracta). Over the decades, PharmExtracta has focused on developing formulations that bridge traditional herbal medicine with modern nutraceutical science. Its R&D department has generated 40 patents and more than 200 scientific publications, reflecting a sustained commitment to research and clinical validation. PharmExtracta organizes its commercial offerings into three distinct lines: Biofarmaceutica, Metabolic Care, and Bacterial Care. These lines address different health areas, from optimizing the bioavailability of nutraceutical substances to metabolic support and probiotic supplementation. The company maintains a direct dialogue with physicians, which informs its product development and positions its formulations as clinically relevant solutions. As of the available evidence, PharmExtracta SpA remains an active company operating primarily in Italy. No further details on ownership, founding year, or executive leadership are provided in the supplied sources.

• Merger of Omeopiacenza s.r.l. and PharmExtracta s.r.l. to form PharmExtracta SpA

• Company has operated in the pharmaceutical and nutraceutical sector for more than 30 years

• Accumulated 40 patents and more than 200 scientific publications

Innovative plant-based biopharmaceutical and nutraceutical formulations supported by patents and scientific publications, developed through physician communication.

• Biofarmaceutica line

  Optimizes the pharmacological and clinical yield of nutraceutical substances and herbal derivatives.

• Metabolic Care line

  Innovative formulations studied for metabolic aspects.

• Bacterial Care line

  Includes typed and safe probiotics and bioproducts.

1. 1PharmExtracta - Biofarmaceutica vegetale per la salutepharmextracta.com
2. 2PharmExtracta SpA (Italy) - Wikidatawikidata.org